# A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD

> **NCT04812262** · PHASE1 · COMPLETED · sponsor: **Neuraly, Inc.** · enrollment: 255 (actual)

## Conditions studied

- Overweight and Obesity
- Type2 Diabetes
- NAFLD

## Interventions

- **DRUG:** DD01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04812262
- **Lead sponsor:** Neuraly, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-24
- **Primary completion:** 2022-12-20
- **Final completion:** 2023-02-14
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2024-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04812262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04812262, "A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04812262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*